Abstract
To determine whether furosemide could prevent renal side effects of indomethacin (INN, indometacin) used for the pharmacologic closure of the patent ductus arteriosus (PDA) in preterm infants.
| Original language | English |
|---|---|
| Pages (from-to) | 181-186 |
| Number of pages | 6 |
| Journal | CLINICAL PHARMACOLOGY & THERAPEUTICS |
| Volume | 62 |
| DOIs | |
| Publication status | Published - 1997 |
Keywords
- Body Weight
- Cyclooxygenase Inhibitors
- Diuretics
- Ductus Arteriosus, Patent
- Female
- Furosemide
- Gestational Age
- Glomerular Filtration Rate
- Humans
- Indomethacin
- Infant, Newborn
- Infant, Premature
- Kidney
- Kidney Diseases
- Male
- Urination
Fingerprint
Dive into the research topics of 'Furosemide does not prevent indomethacin-induced renal side effects in preterm infants'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver